Biểu đồ giá cổ phiếu NMRA
NMRA Thu nhập
Neumora Therapeutics Inc
$1.53
-1.92%
$-0.03
Khi đóng cửa: Jun 17, 16:00:00 GMT-4
$1.53
0%
$0
Phiên trước giờ: Jun 18, 07:12:42 GMT-4
Quay lại
Neumora Therapeutics Inc (NMRA) Thu nhập
Thống kê chính
Giá đóng cửa trước
$1.56
Giá mở cửa
$1.46
Phạm vi ngày
$1.32 - $1.54
Phạm vi 52 tuần
$0.6581 - $3.65
Khối lượng
5.3M
Khối lượng trung bình
1.3M
Tỷ suất cổ tức
--
EPS (TTM)
-1.33
Vốn hóa thị trường
$283.4M
NMRA là gì?
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. The company is headquartered in Watertown, Massachusetts and currently employs 96 full-time employees. The company went IPO on 2023-09-15. The firm's therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Navacaprant is being investigated in the KOASTAL pivotal Phase 3 program, evaluating navacaprant monotherapy in patients with moderate to severe MDD. The firm's next advanced product candidate is NMRA-511, which is a highly selective, novel antagonist of the vasopressin 1a receptor (V1aR) being developed for the treatment of agitation associated with dementia due to Alzheimer's disease (AD).
